ALPHARETTA, Ga., Nov. 8, 2024
/PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced
that Michael Greiner, interim chief executive officer, will
participate in a fireside chat at the UBS 2024 Healthcare
Conference on Tues., Nov. 12 at approximately 2:45 p.m.
Pacific Time.
A webcast of the conference presentation will be available on
the Investors section of the Avanos Medical website and
will be archived on that site.
About Avanos Medical, Inc.
Avanos Medical, Inc. (NYSE: AVNS) is a medical technology
company focused on delivering clinically superior medical device
solutions that will help patients get back to the things that
matter. Headquartered in Alpharetta,
Georgia, we are committed to addressing some of today's most
important healthcare needs, including providing a vital lifeline
for nutrition to patients from hospital to home, and reducing the
use of opioids while helping patients move from surgery to
recovery. We develop, manufacture and market our recognized brands
globally and hold leading market positions in multiple categories
across our portfolio. For more information, visit Avanos.com and
follow Avanos Medical on X (@AvanosMedical), LinkedIn and
Facebook.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-ubs-healthcare-conference-2024-302300375.html
SOURCE Avanos Medical
